Nina Lin MD

Assistant Professor, Infectious Diseases

650 Albany St | (617) 414-5276
Nina Lin
Sections

Infectious Diseases

Biography

Dr. Nina Lin is a physician scientist who is engaged in HIV translational research. Her research is focused on understanding the effect of chronic HIV infection on aging of the immune system and chronic inflammation. She is the PI on several clinical trials, including being a co-Chair of ACTG A5325 and A5220s, to evaluate interventions which may improve or alter the clinical course of chronic HIV infection. Her research while at MGH/BWH had been on understanding HIV-1 coreceptor usage in subtype C infection and the factors associated with its switching. She is the Director of the BU Infectious Disease Clinical Research Unit (CRU) where several HIV and/or infectious diseases clinical studies are being conducted.

Education

Medicine-Internal, MD, Harvard Medical School

Biology, BS, Stanford University

Publications

Published on 7/2/2026

Lin NY, Machiyama H, Kawazoe A, Sai A, Irie T, Habu T, Fukuoka S, Kumanogoh A, Sakamoto N, Ishii G, Kinoshita T, Shitara K, Nishikawa H, Koyama S. Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation. Cancer Immunol Res. 2026 Jul 02; 14(7):1116-1132. PMID: 42044259.

Published on 10/2/2025

Mara MD, Miguel C, Lin NH, Beckwith CG, Henshaw M. Determining the Feasibility of a Mail-In Saliva Sample Protocol for Persons Living with HIV in Two Urban Northeast United States Clinics. HIV AIDS (Auckl). 2025; 17:337-349. PMID: 41064113.

Published on 2/1/2025

Pickering RT, Asundi A, Olson A, Soden K, Kuritzkes DR, Lin NH. Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir. Antivir Ther. 2025 Feb; 30(1):13596535251314571. PMID: 39953931.

Published on 11/1/2023

McLaughlin A, Lin N, Jiang W, Lodi S, Lioznov D, Patts G, Gnatienko N, Blokhina E, Bendiks S, Freiberg MS, Tindle HA, Krupitsky E, Hahn JA, Samet JH, So-Armah K. Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia. J Acquir Immune Defic Syndr. 2023 Nov 01; 94(3):244-252. PMID: 37850982.

Published on 1/10/2022

Asundi A, Olson A, Jiang W, Varshney SP, White LF, Sagar M, Lin NH. Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus. AIDS Res Hum Retroviruses. 2022 03; 38(3):208-215. PMID: 34877881.

Published on 12/28/2021

Kuniholm J, Armstrong E, Bernabe B, Coote C, Berenson A, Patalano SD, Olson A, He X, Lin NH, Fuxman Bass JI, Henderson AJ. Intragenic proviral elements support transcription of defective HIV-1 proviruses. PLoS Pathog. 2021 12; 17(12):e1009982. PMID: 34962974.

Published on 11/2/2021

Ragan EJ, McCallum C, Marathe J, Cole M, Hofman M, Henderson AJ, Flack T, Miller NS, Burks EJ, Zhao GQ, Denis R, Lin NH, Jacobson KR, Andry CD, Pelton SI, Duffy ER, Bhadelia N. Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action. Ann Intern Med. 2021 12; 174(12):1727-1732. PMID: 34724402.

Published on 6/4/2021

Olson A, Coote C, Snyder-Cappione JE, Lin N, Sagar M. HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation. J Infect Dis. 2021 06 04; 223(11):1934-1942. PMID: 33075121.

Published on 6/4/2021

Kamel MH, Mahmoud H, Zhen A, Liu J, Bielick CG, Mostaghim A, Lin N, Chitalia V, Ilori T, Waikar SS, Upadhyay A. End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts. PLoS One. 2021; 16(6):e0252679. PMID: 34086775.

Published on 4/9/2021

Yuen RR, Steiner D, Pihl RMF, Chavez E, Olson A, Smith EL, Baird LA, Korkmaz F, Urick P, Sagar M, Berrigan JL, Gummuluru S, Corley RB, Quillen K, Belkina AC, Mostoslavsky G, Rifkin IR, Kataria Y, Cappione AJ, Gao W, Lin NH, Bhadelia N, Snyder-Cappione JE. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front Immunol. 2021; 12:614676. PMID: 33897682.

View full list of 34 publications.